5110 chromaster pump (Hitachi Ltd)
99
Structured Review
Hitachi Ltd
5110 chromaster pump
5110 Chromaster Pump, supplied by Hitachi Ltd, used in various techniques. Bioz Stars score: 99/100, based on 2003 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5110+chromaster+pump/Chromaster/pmc13000525-99-5-15
Average 99 stars, based on 2003 article reviews
5110 Chromaster Pump, supplied by Hitachi Ltd, used in various techniques. Bioz Stars score: 99/100, based on 2003 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5110+chromaster+pump/Chromaster/pmc13000525-99-5-15
Average 99 stars, based on 2003 article reviews
5110 chromaster pump - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Saline:Article Title: Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW. Article Snippet: .. The system consisted of a Article Title: Roadmap for the accelerated development and clinical translation of fluorescent tracers: Adalimumab-680LT as a proof of concept Article Snippet: .. The system consisted of a Article Title: Roadmap for the accelerated development and clinical translation of fluorescent tracers: Adalimumab-680LT as a proof of concept Article Snippet: .. The system consisted of a High Performance Liquid Chromatography:Article Title: Development, preclinical safety, formulation, and stability of clinical grade bevacizumab-800CW, a new near infrared fluorescent imaging agent for first in human use. Article Snippet: There is a dire need for better visualization of cancer and analysis of specific targets in vivo.. Molecular imaging with fluorescence is gaining more and more attention, as it allows detection of these targets and has advantages over radioactivity, such as no radiation dose, and lower costs.. A key challenge in optical imaging however, is translation of the newly developed tracers from pre-clinical phase to clinical application. Concentration Assay:Article Title: Development, preclinical safety, formulation, and stability of clinical grade bevacizumab-800CW, a new near infrared fluorescent imaging agent for first in human use. Article Snippet: There is a dire need for better visualization of cancer and analysis of specific targets in vivo.. Molecular imaging with fluorescence is gaining more and more attention, as it allows detection of these targets and has advantages over radioactivity, such as no radiation dose, and lower costs.. A key challenge in optical imaging however, is translation of the newly developed tracers from pre-clinical phase to clinical application. |